| DC Field | Value | Language |
|---|
| dc.contributor.author | Budeanu, Razvan-Gabriel | - |
| dc.contributor.author | Jugariu, Anamaria-Romina | - |
| dc.contributor.author | Katona, Timea | - |
| dc.contributor.author | Baetu, Alexandru Emil | - |
| dc.contributor.author | Lates, Gratiana-Andreea | - |
| dc.date.accessioned | 2020-07-02T14:25:55Z | - |
| dc.date.available | 2020-07-02T14:25:55Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | BUDEANU, Razvan-Gabriel, JUGARIU, Anamaria-Romina, KATONA, Timea, BAETU, Alexandru Emil, LATES, Gratiana-Andreea. Treatment of chronic lymphocytic leukemia – a difficult choice for severe complications: a case report. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 27. | en_US |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/10854 | - |
| dc.description | University of Medicine and Pharmacy of Targu Mures | en_US |
| dc.description.abstract | Background. Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia
in the western European countries and is characterized by the relentless accumulation of
monoclonal B cells with the appearance of small mature lymphocytes and with a characteristic
immunophenotype. Even with the right treatment, this disease is known to have a variable
course: some patients die within one year after diagnosis while others live for longer than ten
years. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | en_US |
| dc.subject | chronic lymphocytic leukemia | en_US |
| dc.subject | treatment | en_US |
| dc.subject | drug selection | en_US |
| dc.subject | side effects | en_US |
| dc.title | Treatment of chronic lymphocytic leukemia – a difficult choice for severe complications: a case report | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | MedEspera 2018
|
